- Top Reads
Amgen’s Week 48 phase 3 data showed dazodalibep improved disease activity across several measures in systemic Sjögren’s. The company expects symptomatic-disease results this year.
- Top Reads
BioNTech agreed to pay $205 million for an FDA priority review voucher, giving it a faster review option for a future oncology filing. The company has not named the candidate that will use it as key trials approach milestones.
- Top Reads
When work follows people home, clear boundaries become essential for protecting time, energy, and health. This article shares practical strategies for managing access, organizing tasks, and creating healthier routines. It also includes insights from experts in the field on making boundaries work in everyday life.
- Top Reads
Busy days can make it easy to forget to drink enough water. Simple habits, from refilling before leaving to linking sips with daily routines, can help maintain hydration on the go. Experts in the field share practical tips for making these habits stick.
- Top Reads
The FDA has tentatively approved a generic version of twice-yearly lenacapavir for HIV prevention. The expected price is $40 US per person yearly in countries where it becomes available, though local approvals, funding and delivery will affect timing.
Subscribe to our newsletter
Connect with the Stories That Matter — Subscribe for Exclusive Updates.
A pilot program adapted from an existing mental health intervention shows promise for individuals facing incurable blood cancer. Researchers are evaluating the feasibility of the Be Well Plan, a group-based course, for patients with multiple myeloma and smouldering myeloma. Preliminary results indicated significant improvements in mental wellbeing and empowerment....
- latest in features
